- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03750526
Effectiveness of Augmented Reality and Repetitive Transcranial Magnetic Stimulation
9 de dezembro de 2019 atualizado por: Lai chien hung, Taipei Medical University Hospital
Investigate the Effectiveness of Augmented Reality and Repetitive Transcranial Magnetic Stimulation Technology in Persons With Stroke
This study is to investigate the combined effects of repetitive Transcranial Magnetic Stimulation (rTMS) and Augmented Reality (AR) intervention on cortical excitability, balance, gait, activity in individuals with stroke.
Forty participants will be recruited in this study.
They will be allocated to four group: rTMS and AR group (10), sham rTMS and AR group (10), AR group (10), and conventional physiotherapy group (10).
Visão geral do estudo
Status
Desconhecido
Condições
Descrição detalhada
Participants will be randomized allocated to four groups: rTMS and AR group, sham rTMS and AR group, AR group ,and conventional physiotherapy group in current study.
All participants underwent four weeks, 3 sessions per week, and 60 minutes per session training program.
Motor evoked potential (MEP), Time up go test (TUG), Berg Balance Scale (BBS), Fugl-Meyer Assessment (FMA), Multi-directional Reach Test (MDRT),The Postural Assessment Scale for Stroke Patients (PASS), and Taiwanese Depression Questionnaires (TDQ) will be assessed before and after intervention in all participants.
Tipo de estudo
Intervencional
Inscrição (Antecipado)
40
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Taipei, Taiwan
- Recrutamento
- Taipei Medical University Hospital
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
20 anos a 80 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Cognitive ability is sufficient to understand the nature of study (Mini-Mental State Examination score was above 23).
- Participants suffer from unilateral hemiplegia caused by a first-ever stroke.
- Participants are stable in medical and psychological condition.
Exclusion Criteria:
- Participants have other neurologic problems that can affect balance and walking ability.
- Participants take of drugs or have other medical condition that can affect balance and function.
- Participants have contraindications for rTMS intervention such as pacemaker, cochlear implants, metal in the brain or skull, open wound of brain, or history of epilepsy.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: rTMS and AR group
Ten participants in group A will undergo repetitive transcranial magnetic stimulation (real, 1 Hz, 15 minutes), follow by a session of augmented reality exercise (45 minutes), 3 days per week for 4 weeks.
|
rTMS performs 1Hz,15 minutes real rTMS.
AR intervention contains weight-shift exercise, strengthening of lower limb and balance training for 45 minutes.
|
|
Comparador Ativo: Sham rTMS and AR group
Ten participants in group B will receive repetitive transcranial magnetic stimulation (sham,1 Hz, 15 minutes), follow by a session of augmented reality exercise (45 minutes), 3 days per week for 4 weeks.
|
Sham rTMS applies 1Hz, 15 minutes sham rTMS.
AR intervention includes weight-shift exercise, strengthening of lower limb and balance training for 45 minutes.
|
|
Comparador Ativo: AR group
Ten participants in group C will undergo augmented reality exercise 60 minutes a day and 3 days per week for four weeks.
|
AR intervention contains weight-shift exercise, strengthening of lower limb and balance training for 60 minutes.
|
|
Comparador Ativo: Conventional physiotherapy group
Ten participants allocated to the group D will receive conventional physiotherapy 60 minutes a day and 3 days per week for four weeks.
|
Conventional physiotherapy includes rolling, sitting, balance exercise, standing, overground walking, facilitation of the paretic limbs, and so on for 60 minutes.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change of Time Up Go test (TUG)
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
The TUG test will ask participants to stand up, walk for 3 m, turn, walk back and sit down as fast as they can during the test, and the time requires for each patient to complete the test is recorded.
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change of Berg Balance Scale (BBS)
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Participants performed a series of 14 functional balance tasks, including maintaining a quiet stance, sitting-to-standing, shifting weight and reaching, turning in place, standing on one leg, and maintaining a tandem stance.
Each task was scored on a 5-point ordinal scale (from 0 to 4).
A score of 0 denotes the inability of the participant to perform the task, and a score of 4 denotes that the participant can complete the task based on a preset criterion.
The highest possible score is 56.
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
|
Change of Motor evoked potential (MEP)
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Motor evoked potential (MEP) is recorded from tibialis anterior muscles following direct transcranial magnetic stimulation (TMS) of motor cortex.
All TMS is delivered with the participant seated upright on the chair.
Both passive and active conditions, participants are instructed to relax their right leg in the seated position.
TMS is delivered over the motor cortex (M1) using a concave double cone coil (Magstim Co., United Kingdom) attached to a BiStim magnetic stimulator (Magstim Co., United Kingdom).
To locate the optimal site, stimuli are delivered over various points along the M1.
The optimal site is the location on the M1 that evoked the greatest MEP amplitude in the bilateral tibialis anterior muscles.
The onset latency and onset to peak amplitude will be assessed.
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
|
Change of Fugl-Meyer Assessment (FMA)-Lower extremity
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Fugl-Meyer Assessment-Lower extremity is used to measure lower-limb recovery in stroke rehabilitation studies.The scale has 6 items ranging from reflex activity to voluntary motor control.
Each item further comprises components, with a total of 17. Scoring is done on a 3-point ordinal scale ranges from 0 (no performance) to 2 (faultless performance).
The total score range from 0 (no motor function) to 34 (good motor recovery).
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
|
Change of Multi-directional Reach Test (MDRT)
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Participants will be required to reach in the forward, left and right directions.
The test is performed with the participant in standing.
It is the measure of the difference, in centimeters, between arm's length with arms at 90° flexion/ abduction and maximal forward, left and right directions reaching respectively, using a fixed base of support.
The test uses a centimeters measuring device against a wall at shoulder height.
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
|
Change of The Postural Assessment Scale for Stroke Patients (PASS)
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
The Postural Assessment Scale for Stroke Patients (PASS) is a postural assessment scale specifically designed to assess and monitor postural control after stroke.
It contains 12 four-level items of varying difficulty for assessing ability to maintain or change a given lying, sitting, or standing posture.
The PASS consists of 2 sections with a 4-point scale to describe each task.
The total score ranges from 0 - 36.
A score of 0 denotes the inability of the participant to perform the task, and a score of 3 denotes that the participant can complete the task based on a preset criterion.
The highest possible score is 36.
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
|
Change of Taiwanese Depression Questionnaires (TDQ)
Prazo: Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Taiwanese Depression Questionnaires (TDQ) contains 18 items to screen the situation of depression within a week.
The TDQ, which is a 4-point scale with 18 items, is a culturally specific depression self-rating instrument for effective screening of depression in Taiwan and has satisfactory reliability and validity.
Subjects are guided to rate each item on a scale from 0 to 3 on the basis of "how often you felt the physical and emotional aspects during the past week".
Zero denotes never, three means always.
TDQ scores range from 0 to 54.
|
Measurement before and after intervention ( week 0 and at the end of week 4) in four groups
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
31 de julho de 2018
Conclusão Primária (Antecipado)
30 de outubro de 2020
Conclusão do estudo (Antecipado)
30 de dezembro de 2020
Datas de inscrição no estudo
Enviado pela primeira vez
20 de novembro de 2018
Enviado pela primeira vez que atendeu aos critérios de CQ
20 de novembro de 2018
Primeira postagem (Real)
23 de novembro de 2018
Atualizações de registro de estudo
Última Atualização Postada (Real)
11 de dezembro de 2019
Última atualização enviada que atendeu aos critérios de controle de qualidade
9 de dezembro de 2019
Última verificação
1 de dezembro de 2019
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- N201703084
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .